查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386414

大肠诊断市场报告：2030 年趋势、预测与竞争分析

Colorectal Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

大肠诊断的趋势和预测

到 2030 年，全球大肠肠癌诊断市场预计将达到 56 亿美元，2024 年至 2030 年年复合成长率为 8.5%。该市场的主要驱动因素是癌症盛行率的增加、意识的提高和早期诊断治疗以及医疗保健支出的增加。全球大肠直肠癌诊断市场的未来前景广阔，医院、诊断中心、癌症研究中心和门诊手术中心市场存在商机。

大肠直肠癌诊断市场洞察

Lucintel 预测，由于癌症诊断的医疗保健支出增加以及对预防性护理的偏好增加，设备将在预测期内实现最高增长。

在这个市场中，由于对大肠疾病具有成本效益的诊断设施的需求不断增长以及全球诊断中心数量的不断增加，诊断中心仍然是最大的部分。

由于先进的诊断程序和技术的可用性以及对大肠诊断测试的需求不断增加，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球大肠直肠癌诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球大肠直肠癌诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球大肠诊断市场
    • 装置
    • 消耗品及配件
  • 按癌症类型分類的全球大肠诊断市场
    • 腺癌
    • 大肠淋巴瘤
    • 胃肠道基质肿瘤
    • 类癌瘤
    • 其他的
  • 按年龄组别分類的全球大肠诊断市场
    • 老年人
    • 成人
    • 儿童
  • 全球大肠诊断市场（依最终用途）
    • 医院
    • 诊断中心
    • 癌症研究中心
    • 门诊手术中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球大肠诊断市场（按地区）
  • 北美大肠直肠癌诊断市场
  • 欧洲大肠直肠癌诊断市场
  • 亚太大肠诊断市场
  • 其他地区大肠直肠癌大肠市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球大肠诊断市场成长机会
    • 按癌症类型分類的全球大肠诊断市场成长机会
    • 按年龄组别分類的全球大肠诊断市场的成长机会
    • 按最终用途分類的全球大肠诊断市场的成长机会
    • 全球大肠诊断市场按地区成长机会
  • 全球大肠直肠癌诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球大肠直肠癌诊断市场的产能
    • 全球大肠直肠癌诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck
简介目录

Colorectal Cancer Diagnostic Trends and Forecast

The future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets. The global colorectal cancer diagnostic market is expected to reach an estimated $5.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer Diagnostic by Segment

The study includes a forecast for the global colorectal cancer diagnostic by product type, cancer type, age group, end use, and region.

Colorectal Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables & Accessories

Colorectal Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Adenocarcinoma
  • Colorectal Lymphoma
  • Gastrointestinal Stromal Tumors
  • Carcinoid Tumors
  • Others

Colorectal Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Geriatric
  • Adults
  • Pediatric

Colorectal Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Ambulatory Surgical Centers
  • Others

Colorectal Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Colorectal Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer diagnostic companies profiled in this report include-

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck

Colorectal Cancer Diagnostic Market Insights

Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Within this market, diagnostic centers will remain the largest segment due to growing need for cost effective diagnosis facilities for colorectal cancer disease and rising number of diagnostic centers globally.

North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Features of the Global Colorectal Cancer Diagnostic Market

Market Size Estimates: Colorectal cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer diagnostic market size by various segments, such as by product type, cancer type, age group, end use, and region in terms of ($B).

Regional Analysis: Colorectal cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, age groups, end uses, and regions for the colorectal cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the colorectal cancer diagnostic market size?

Answer: The global colorectal cancer diagnostic market is expected to reach an estimated $5.6 billion by 2030.

Q.2 What is the growth forecast for colorectal cancer diagnostic market?

Answer: The global colorectal cancer diagnostic market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the colorectal cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures and increasing healthcare expenditure.

Q4. What are the major segments for colorectal cancer diagnostic market?

Answer: The future of the colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.

Q5. Who are the key colorectal cancer diagnostic market companies?

Answer: Some of the key colorectal cancer diagnostic companies are as follows:

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck

Q6. Which colorectal cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Q7. In colorectal cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer diagnostic market by product type (instruments and consumables & accessories), cancer type (adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others), age group (geriatric, adults, and pediatric), end use (hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Colorectal Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Colorectal Cancer Diagnostic Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables & Accessories
  • 3.4: Global Colorectal Cancer Diagnostic Market by Cancer Type
    • 3.4.1: Adenocarcinoma
    • 3.4.2: Colorectal Lymphoma
    • 3.4.3: Gastrointestinal Stromal Tumors
    • 3.4.4: Carcinoid Tumors
    • 3.4.5: Others
  • 3.5: Global Colorectal Cancer Diagnostic Market by Age Group
    • 3.5.1: Geriatric
    • 3.5.2: Adults
    • 3.5.3: Pediatric
  • 3.6: Global Colorectal Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Diagnostic Centers
    • 3.6.3: Cancer Research Centers
    • 3.6.4: Ambulatory Surgical Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Colorectal Cancer Diagnostic Market by Region
  • 4.2: North American Colorectal Cancer Diagnostic Market
    • 4.2.2: North American Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.3: European Colorectal Cancer Diagnostic Market
    • 4.3.1: European Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.3.2: European Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Colorectal Cancer Diagnostic Market
    • 4.4.1: APAC Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.4.2: APAC Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Colorectal Cancer Diagnostic Market
    • 4.5.1: ROW Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.5.2: ROW Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Colorectal Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: Siemens Healthcare
  • 7.3: Koninklijke Philips
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Abbott
  • 7.6: Illumina
  • 7.7: QIAGEN
  • 7.8: Thermo Fisher Scientific
  • 7.9: Quest Diagnostics
  • 7.10: Merck